Category: BIOTECHNOLOGY & MEDICAL RESEARCH

Here, the technique is used to produce pharmaceutical drugs as well as other chemicals to combat diseases. It involves the study of bacteria, plant and animal cells to first understand the way they function at a fundamental level.

πŸ΄β€β˜ οΈ CO-DIAGNOSTICS USD (CODX-USD)

By jatslo

Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and…

πŸ΄β€β˜ οΈ CARA THERAPEUTICS USD (CARA-USD)

By jatslo

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body’s peripheral…

πŸ΄β€β˜ οΈ MACROGENICS USD (MGNX-USD)

By jatslo

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody…

πŸ΄β€β˜ οΈ SAGE THERAPEUTICS USD (SAGE-USD)

By jatslo

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company’s lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a neurosteroid…

πŸ΄β€β˜ οΈ VERTEX PHARMACEUTICALS USD (VRTX-USD)

By jatslo

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs…

πŸ΄β€β˜ οΈ HEAT BIOLOGICS USD (HTBX-USD)

By jatslo

Heat Biologics, Inc. is a development-stage company focused on developing allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers. The Company is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT)…

πŸ΄β€β˜ οΈ CLOVIS ONCOLOGY USD (CLVS-USD)

By jatslo

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose…

πŸ΄β€β˜ οΈ MODERNA USD (MRNA-USD)

By jatslo

Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing…

πŸ΄β€β˜ οΈ MERRIMACK PHARMACEUTICALS USD (MACK-USD)

By jatslo

Merrimack Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in designing novel treatments for cancer by targeting biomarker-defined cancers. Its clinical programs include MM-121 (seribantumab), MM-141 (istiratumab) and MM-310. MM-121 is a fully human monoclonal antibody…

πŸ΄β€β˜ οΈ TG THERAPEUTICS USD (TGTX-USD)

By jatslo

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab)….

πŸ΄β€β˜ οΈ SORRENTO THERAPEUTICS USD (SRNE-USD)

By jatslo

Sorrento Therapeutics, Inc. is a clinical-stage and commercial biopharma company. The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery…

πŸ΄β€β˜ οΈ AMARIN USD (AMRN-USD)

By jatslo

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company’s lead product, Vascepa…

πŸ΄β€β˜ οΈ VBI VACCINES USD (VBIV-USD)

By jatslo

VBI Vaccines Inc. is a development-stage biotechnology company. The Company’s principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development…

πŸ΄β€β˜ οΈ NEKTAR THERAPEUTICS USD (NKTR-USD)

By jatslo

Nektar Therapeutics is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Company’s research and development pipeline of new investigational drugs includes treatments for cancer and autoimmune disease. It leverages its chemistry platform to discover…

πŸ΄β€β˜ οΈ INOVIO PHARMACEUTICALS USD (INO-USD)

By jatslo

Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company’s DNA-based immunotherapies, in combination with its…

πŸ΄β€β˜ οΈ ARENA PHARMACEUTICALS USD (ARNA-USD)

By jatslo

Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering…

πŸ΄β€β˜ οΈ TREVENA USD (TRVN-USD)

By jatslo

Trevena Inc. is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator (u-GPS) for the management of moderate-to-severe acute pain where intravenous (IV) administration is preferred. It is focused…

πŸ΄β€β˜ οΈ MINERVA NEUROSCIENCES USD (NERV-USD)

By jatslo

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company’s product portfolio and indications include…

πŸ΄β€β˜ οΈ VIR BIOTECHNOLOGY USD (VIR-USD)

By jatslo

Vir Biotechnology, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments to treat and prevent serious infectious diseases. Its technology platforms are focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA). Its pipeline consists…

πŸ΄β€β˜ οΈ MICROBOT MEDICAL USD (MBOT-USD)

By jatslo

Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged…